Cellular Senescence in Cancer and Aging

Cell - Tập 130 - Trang 223-233 - 2007
Manuel Collado1, Maria A. Blasco1, Manuel Serrano1
1Spanish National Cancer Research Center (CNIO), Madrid, Spain

Tài liệu tham khảo

Artandi, 2000, Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice, Nature, 406, 641, 10.1038/35020592 Barlow, 1996, Atm-deficient mice: a paradigm of ataxia telangiectasia, Cell, 86, 159, 10.1016/S0092-8674(00)80086-0 Bartkova, 2006, Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints, Nature, 444, 633, 10.1038/nature05268 Beausejour, 2003, Reversal of human cellular senescence: roles of the p53 and p16 pathways, EMBO J., 22, 4212, 10.1093/emboj/cdg417 Blanco, 2007, Telomerase abrogation dramatically accelerates TRF2-induced epithelial carcinogenesis, Genes Dev., 21, 206, 10.1101/gad.406207 Blasco, 2005, Telomeres and human disease: ageing, cancer and beyond, Nat. Rev. Genet., 6, 611, 10.1038/nrg1656 Blasco, 1997, Telomere shortening and tumor formation by mouse cells lacking telomerase RNA, Cell, 91, 25, 10.1016/S0092-8674(01)80006-4 Bodnar, 1998, Extension of life-span by introduction of telomerase into normal human cells, Science, 279, 349, 10.1126/science.279.5349.349 Bracken, 2007, The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells, Genes Dev., 21, 525, 10.1101/gad.415507 Braig, 2005, Oncogene-induced senescence as an initial barrier in lymphoma development, Nature, 436, 660, 10.1038/nature03841 Canela, 2004, Constitutive expression of tert in thymocytes leads to increased incidence and dissemination of T-cell lymphoma in Lck-Tert mice, Mol. Cell. Biol., 24, 4275, 10.1128/MCB.24.10.4275-4293.2004 Canela, 2007, High-throughput telomere length quantification by FISH and its application to human population studies, Proc. Natl. Acad. Sci. USA, 104, 5300, 10.1073/pnas.0609367104 Cao, 2003, Senescence, aging, and malignant transformation mediated by p53 in mice lacking the Brca1 full-length isoform, Genes Dev., 17, 201, 10.1101/gad.1050003 Cawthon, 2003, Association between telomere length in blood and mortality in people aged 60 years or older, Lancet, 361, 393, 10.1016/S0140-6736(03)12384-7 Chan, 2001, Altering telomere structure allows telomerase to act in yeast lacking ATM kinases, Curr. Biol., 11, 1240, 10.1016/S0960-9822(01)00391-8 Chen, 2005, Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis, Nature, 436, 725, 10.1038/nature03918 Cheng, 2000, Hematopoietic stem cell quiescence maintained by p21cip1/waf1, Science, 287, 1804, 10.1126/science.287.5459.1804 Chin, 1999, p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis, Cell, 97, 527, 10.1016/S0092-8674(00)80762-X Chkhotua, 2003, Increased expression of p16(INK4a) and p27(Kip1) cyclin-dependent kinase inhibitor genes in aging human kidney and chronic allograft nephropathy, Am. J. Kidney Dis., 41, 1303, 10.1016/S0272-6386(03)00363-9 Choudhury, 2007, Cdkn1a deletion improves stem cell function and lifespan of mice with dysfunctional telomeres without accelerating cancer formation, Nat. Genet., 39, 99, 10.1038/ng1937 Christophorou, 2006, The pathological response to DNA damage does not contribute to p53-mediated tumour suppression, Nature, 443, 214, 10.1038/nature05077 Collado, 2006, The power and the promise of oncogene-induced senescence markers, Nat. Rev. Cancer, 6, 472, 10.1038/nrc1884 Collado, 2005, Tumour biology: senescence in premalignant tumours, Nature, 436, 642, 10.1038/436642a Collins, 2002, Telomerase in the human organism, Oncogene, 21, 564, 10.1038/sj.onc.1205083 Courtois-Cox, 2006, A negative feedback signaling network underlies oncogene-induced senescence, Cancer Cell, 10, 459, 10.1016/j.ccr.2006.10.003 Coviello-McLaughlin, 1997, Telomere length regulation during postnatal development and ageing in Mus spretus, Nucleic Acids Res., 25, 3051, 10.1093/nar/25.15.3051 d'Adda di Fagagna, 2003, A DNA damage checkpoint response in telomere-initiated senescence, Nature, 426, 194, 10.1038/nature02118 Dankort, 2007, A new mouse model to explore the initiation, progression, and therapy of BRAFV600E-induced lung tumors, Genes Dev., 21, 379, 10.1101/gad.1516407 de Lange, 2005, Shelterin: the protein complex that shapes and safeguards human telomeres, Genes Dev., 19, 2100, 10.1101/gad.1346005 Di Micco, 2006, Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication, Nature, 444, 638, 10.1038/nature05327 Dimri, 1995, A biomarker that identifies senescent human cells in culture and in aging skin in vivo, Proc. Natl. Acad. Sci. USA, 92, 9363, 10.1073/pnas.92.20.9363 Efeyan, 2006, Tumour biology: Policing of oncogene activity by p53, Nature, 443, 159, 10.1038/443159a Epel, 2004, Accelerated telomere shortening in response to life stress, Proc. Natl. Acad. Sci. USA, 101, 17312, 10.1073/pnas.0407162101 Feldser, 2007, Short telomeres limit tumor progression in vivo by inducing senescence, Cancer Cell, 11, 461, 10.1016/j.ccr.2007.02.026 Ferguson, 2001, DNA double strand break repair and chromosomal translocation: lessons from animal models, Oncogene, 20, 5572, 10.1038/sj.onc.1204767 Flores, 2005, Effects of telomerase and telomere length on epidermal stem cell behavior, Science, 309, 1253, 10.1126/science.1115025 Flores, 2006, Telomerase regulation and stem cell behaviour, Curr. Opin. Cell Biol., 18, 254, 10.1016/j.ceb.2006.03.003 Garcia-Cao, 2002, “Super p53” mice exhibit enhanced DNA damage response, are tumor resistant and age normally, EMBO J., 21, 6225, 10.1093/emboj/cdf595 Garcia-Cao, 2006, Increased p53 activity does not accelerate telomere-driven ageing, EMBO Rep., 7, 546, 10.1038/sj.embor.7400667 Gil, 2006, Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all, Nat. Rev. Mol. Cell Biol., 7, 667, 10.1038/nrm1987 Gonzalez-Suarez, 2001, Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes, EMBO J., 20, 2619, 10.1093/emboj/20.11.2619 Gonzalez-Suarez, 2005, Antagonistic effects of telomerase on cancer and aging in K5-mTert transgenic mice, Oncogene, 24, 2256, 10.1038/sj.onc.1208413 Greider, 1985, Identification of a specific telomere terminal transferase activity in Tetrahymena extracts, Cell, 43, 405, 10.1016/0092-8674(85)90170-9 Ha, 2007, ARF functions as a melanoma tumor suppressor by inducing p53-independent senescence, Proc. Natl. Acad. Sci. USA, 104, 10968, 10.1073/pnas.0611638104 Hahn, 2002, Rules for making human tumor cells, N. Engl. J. Med., 347, 1593, 10.1056/NEJMra021902 Hamilton, 2001, Does oxidative damage to DNA increase with age?, Proc. Natl. Acad. Sci. USA, 98, 10469, 10.1073/pnas.171202698 Harley, 1990, Telomeres shorten during ageing of human fibroblasts, Nature, 345, 458, 10.1038/345458a0 Hayflick, 1961, The serial cultivation of human diploid cell strains, Exp. Cell Res., 25, 585, 10.1016/0014-4827(61)90192-6 Helgadottir, 2007, A common variant on chromosome 9p21 affects the risk of myocardial infarction, Science, 316, 1491, 10.1126/science.1142842 Herbig, 2006, Cellular senescence in aging primates, Science, 311, 1257, 10.1126/science.1122446 Ito, 2006, Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells, Nat. Med., 12, 446, 10.1038/nm1388 Iwasa, 2003, Mitogen-activated protein kinase p38 defines the common senescence-signalling pathway, Genes Cells, 8, 131, 10.1046/j.1365-2443.2003.00620.x Jacobs, 1999, The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus, Nature, 397, 164, 10.1038/16476 Janzen, 2006, Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a, Nature, 443, 421, 10.1038/nature05159 Kelland, 2005, Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics–current status and future prospects, Eur. J. Cancer, 41, 971, 10.1016/j.ejca.2004.11.024 Kim, 2006, The regulation of INK4/ARF in cancer and aging, Cell, 127, 265, 10.1016/j.cell.2006.10.003 Krimpenfort, 2001, Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice, Nature, 413, 83, 10.1038/35092584 Krishnamurthy, 2004, Ink4a/Arf expression is a biomarker of aging, J. Clin. Invest., 114, 1299, 10.1172/JCI22475 Krishnamurthy, 2006, p16INK4a induces an age-dependent decline in islet regenerative potential, Nature, 443, 453, 10.1038/nature05092 Krtolica, 2001, Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging, Proc. Natl. Acad. Sci. USA, 98, 12072, 10.1073/pnas.211053698 Lazzerini Denchi, 2005, Deregulated E2F activity induces hyperplasia and senescence-like features in the mouse pituitary gland, Mol. Cell. Biol., 25, 2660, 10.1128/MCB.25.7.2660-2672.2005 Lee, 1998, Essential role of mouse telomerase in highly proliferative organs, Nature, 392, 569, 10.1038/33345 Lim, 2000, Analysis of ku80-mutant mice and cells with deficient levels of p53, Mol. Cell. Biol., 20, 3772, 10.1128/MCB.20.11.3772-3780.2000 Lombard, 2005, DNA repair, genome stability, and aging, Cell, 120, 497, 10.1016/j.cell.2005.01.028 Maier, 2004, Modulation of mammalian life span by the short isoform of p53, Genes Dev., 18, 306, 10.1101/gad.1162404 Mallette, 2007, The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence, Genes Dev., 21, 43, 10.1101/gad.1487307 Mason, 2004, Heterozygous telomerase deficiency in mouse and man: when less is definitely not more, Cell Cycle, 3, 1127, 10.4161/cc.3.9.1109 Matheu, 2004, Increased gene dosage of Ink4a/Arf results in cancer resistance and normal aging, Genes Dev., 18, 2736, 10.1101/gad.310304 Matheu, 2007, Delayed ageing through damage protection by the Arf/p53 pathway, Nature, 10.1038/nature05949 McPherson, 2007, A common allele on chromosome 9 associated with coronary heart disease, Science, 316, 1488, 10.1126/science.1142447 Melzer, 2007, A common variant of the p16(INK4a) genetic region is associated with physical function in older people, Mech. Ageing Dev., 10.1016/j.mad.2007.03.005 Mendrysa, 2006, Tumor suppression and normal aging in mice with constitutively high p53 activity, Genes Dev., 20, 16, 10.1101/gad.1378506 Michaloglou, 2005, BRAFE600-associated senescence-like cell cycle arrest of human naevi, Nature, 436, 720, 10.1038/nature03890 Molofsky, 2006, Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing, Nature, 443, 448, 10.1038/nature05091 Muntoni, 2005, The first molecular details of ALT in human tumor cells, Hum. Mol. Genet., 14, R191, 10.1093/hmg/ddi266 Niedernhofer, 2006, A new progeroid syndrome reveals that genotoxic stress suppresses the somatotroph axis, Nature, 444, 1038, 10.1038/nature05456 Ogami, 2004, Telomere shortening in human coronary artery diseases, Arterioscler. Thromb. Vasc. Biol., 24, 546, 10.1161/01.ATV.0000117200.46938.e7 Ohtani, 2001, Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence, Nature, 409, 1067, 10.1038/35059131 Panossian, 2003, Telomere shortening in T cells correlates with Alzheimer's disease status, Neurobiol. Aging, 24, 77, 10.1016/S0197-4580(02)00043-X Parrinello, 2003, Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts, Nat. Cell Biol., 5, 741, 10.1038/ncb1024 Ramirez, 2001, Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions, Genes Dev., 15, 398, 10.1101/gad.859201 Rehen, 2005, Constitutional aneuploidy in the normal human brain, J. Neurosci., 25, 2176, 10.1523/JNEUROSCI.4560-04.2005 Ressler, 2006, p16INK4A is a robust in vivo biomarker of cellular aging in human skin, Aging Cell, 5, 379, 10.1111/j.1474-9726.2006.00231.x Roberson, 2005, Escape from therapy-induced accelerated cellular senescence in p53-null lung cancer cells and in human lung cancers, Cancer Res., 65, 2795, 10.1158/0008-5472.CAN-04-1270 Sablina, 2005, The antioxidant function of the p53 tumor suppressor, Nat. Med., 11, 1306, 10.1038/nm1320 Sarin, 2005, Conditional telomerase induction causes proliferation of hair follicle stem cells, Nature, 436, 1048, 10.1038/nature03836 Sarkisian, 2007, Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis, Nat. Cell Biol., 9, 493, 10.1038/ncb1567 Satyanarayana, 2003, Telomere shortening impairs organ regeneration by inhibiting cell cycle re-entry of a subpopulation of cells, EMBO J., 22, 4003, 10.1093/emboj/cdg367 Saxena, 2007, Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels, Science, 316, 1331, 10.1126/science.1142358 Scott, 2007, A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants, Science, 316, 1341, 10.1126/science.1142382 Sedelnikova, 2004, Senescing human cells and ageing mice accumulate DNA lesions with unrepairable double-strand breaks, Nat. Cell Biol., 6, 168, 10.1038/ncb1095 Serrano, 1993, A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4, Nature, 366, 704, 10.1038/366704a0 Serrano, 1996, Role of the INK4a locus in tumor suppression and cell mortality, Cell, 85, 27, 10.1016/S0092-8674(00)81079-X Serrano, 1997, Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a, Cell, 88, 593, 10.1016/S0092-8674(00)81902-9 Shammas, 2005, Telomerase inhibition by siRNA causes senescence and apoptosis in Barrett's adenocarcinoma cells: mechanism and therapeutic potential, Mol. Cancer, 4, 24, 10.1186/1476-4598-4-24 Sharpless, 2005, INK4a/ARF: a multifunctional tumor suppressor locus, Mutat. Res., 576, 22, 10.1016/j.mrfmmm.2004.08.021 Sharpless, 2001, Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis, Nature, 413, 86, 10.1038/35092592 Siegl-Cachedenier, 2007, Deficient mismatch repair improves organismal fitness and survival of mice with dysfunctional telomeres, Genes Dev., 10.1101/gad.430107 Stewart, 2006, Telomeres: cancer to human aging, Annu. Rev. Cell Dev. Biol., 22, 531, 10.1146/annurev.cellbio.22.010305.104518 te Poele, 2002, DNA damage is able to induce senescence in tumor cells in vitro and in vivo, Cancer Res., 62, 1876 Tyner, 2002, p53 mutant mice that display early ageing-associated phenotypes, Nature, 415, 45, 10.1038/415045a Valdes, 2005, Obesity, cigarette smoking, and telomere length in women, Lancet, 366, 662, 10.1016/S0140-6736(05)66630-5 Valk-Lingbeek, 2004, Stem cells and cancer; the polycomb connection, Cell, 118, 409, 10.1016/j.cell.2004.08.005 Varela, 2005, Accelerated ageing in mice deficient in Zmpste24 protease is linked to p53 signalling activation, Nature, 437, 564, 10.1038/nature04019 Ventura, 2007, Restoration of p53 function leads to tumour regression in vivo, Nature, 445, 661, 10.1038/nature05541 Vijg, 2000, Somatic mutations and aging: a re-evaluation, Mutat. Res., 447, 117, 10.1016/S0027-5107(99)00202-X von Zglinicki, 2005, Telomeres as biomarkers for ageing and age-related diseases, Curr. Mol. Med., 5, 197, 10.2174/1566524053586545 von Zglinicki, 2005, Human cell senescence as a DNA damage response, Mech. Ageing Dev., 126, 111, 10.1016/j.mad.2004.09.034 Wang, 2002, Sequential activation of the MEK-extracellular signal-regulated kinase and MKK3/6-p38 mitogen-activated protein kinase pathways mediates oncogenic ras-induced premature senescence, Mol. Cell. Biol., 22, 3389, 10.1128/MCB.22.10.3389-3403.2002 Weaver, 2007, Aneuploidy acts both oncogenically and as a tumor suppressor, Cancer Cell, 11, 25, 10.1016/j.ccr.2006.12.003 Woo, 2004, Activated oncogenes promote and cooperate with chromosomal instability for neoplastic transformation, Genes Dev., 18, 1317, 10.1101/gad.1165204 Xue, 2007, Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas, Nature, 445, 656, 10.1038/nature05529 Zeggini, 2007, Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes, Science, 316, 1336, 10.1126/science.1142364 Zindy, 1997, Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging, Oncogene, 15, 203, 10.1038/sj.onc.1201178